Event starts on August 20, 2019 10:00 AM
Add to favorites
  • Price
  • Ends August 20, 2019 11:30 AM
  • Location Others
  • Category Uncategorized
  • Created June 25, 2019
  • Author Roger Steven

Product Description

Overview:

For much of healthcare, HIPAA sets the standards for how to manage uses and disclosures of patient information, known as Protected Health Information (PHI).

But when it comes to information related to the treatment of substance use disorders, regulations of the Substance Abuse and Mental Health Services Administration (SAMHSA) under 42 CFR Part 2 prevail, including rigorous controls on the release and re-release of patient information.

Why should you Attend: While HIPAA rules apply to all Protected Health Information, the rules under 42 CFR Part 2 place special limitations on substance use disorder-related information. HIPAA has controls on the release of health information, but once it’s released under HIPAA, the information is allowed to be used according to the regulations and obligations of the receiving party.

With information under Part 2, the obligations to protect the information travel with the information, placing recipients under obligations to provide further protection under Part 2 rules.

For decades, the rules under 42 CFR Part 2 have required that each and every release of information have a consent in place, but new rules allow release to “others involved in my care,” including re-release of information without a new consent.

While this new option promises to simplify the release and re-release of information, implementation requires that it be possible to report to the individual a list of parties to whom the information has been released. The accounting for these disclosures is similar to the HIPAA accounting of disclosures in principle, but applies to treatment disclosures all the way down the chain of releases.

HIPAA allows a number of disclosures, for treatment, payment, and healthcare operations purposes, without consent from the individual being treated.

SAMHSA rules, on the other hand, require consent for every disclosure or re-disclosure, and if the proper consents aren’t obtained, the provider can be in violation of the rules and subject to penalties.

Areas Covered in the Session:

What HIPAA allows, what SAMHSA requires, and the differences will be explained
We will Examine how to Determine if the services you provide place you under 42 CFR Part 2
We will explore the means for making sure substance abuse Treatment Information Receives the Appropriate Protections
The Consent and Release Requirements under HIPAA will be explained
The consent and Release Requirements under 42 CFR Part 2 will be explained
Re-release of Information released under 42 CFR Part 2 will be discussed
Sharing of Information with Family and Friends in an overdose Incident will be explored
Requirements for Providing an accounting of disclosures of Part 2 Information will be Explained
Challenges in Managing mixed records with Some Part 2 and some non-Part 2 Data will be Discussed

Who Will Benefit:
Compliance Director
CEO
CFO
Privacy Officer
Security Officer
Information Systems Manager
HIPAA Officer
Chief Information Officer
Health Information Manager
Healthcare Counsel/Lawyer
Office Manager
Jim Sheldon Dean – MentorHealth Speaker Profile
Jim Sheldon-Dean is the founder and director of compliance services at Lewis Creek Systems, LLC, a Vermont-based consulting firm founded in 1982, providing information privacy and security regulatory compliance services to a wide variety of health care entities.

Event link: https://www.mentorhealth.com/webinar/-801716LIVE?channel=tixtore-august_2019_SEO
Contact Info:
Netzealous LLC – MentorHealth
Phone No: 1-800-385-1607
Fax: 302-288-6884
Email: mentorhealth84@gmail.com
Website: http://www.mentorhealth.com/

Amenities

  • E-Ticket

Contact

Website
https://www.mentorhealth.com/webinar/-801716LIVE?channel=tixtore-august_2019_SEO
Address
Online Event

Reviews

There are no reviews yet.

Be the first to review “HIPAA, Consents, and 42 CFR Part 2 – Tracking the Release of Information Under Conflicting Rules”

Your email address will not be published. Required fields are marked *

Available Tickets

Contact Listing Owner